Latest filing published 25 Jul 2025 for IGM Biosciences, Inc., €4,766.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lisa Lynn Decker is a declared insider of IGM Biosciences, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 15 November 2021 to 23 July 2025, the count stands at 29 filings.
On the market, this insider has only sold: 18 sales, €221k in total. Other entries cover 11 share grants. In 2025 alone, the filings show no purchases and 3 sales.
Most recently, on 25 July 2025, the filings show an open-market sale worth €4,766 in IGM Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations